SCHEMBL4046157

SCHEMBL4046157

Cc1oc2c(C)c(C)c(O)c(C)c2c1-c1ccc(C(C)C)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCL2 P10415 2/20 0.41
MCL1 Q07820 2/20 0.41
BAD Q92934 1/20 0.41
GAA P10253 3/20 0.37
CSNK2A2 P19784 1/20 0.36
CSNK2B P67870 1/20 0.36
CSNK2A1 P68400 1/20 0.36
PTGS1 P23219 2/20 0.36
PTGS2 P35354 1/20 0.36
RNASEH1 O60930 1/20 0.35
TRPA1 O75762 1/20 0.34
CACNA1C Q13936 1/20 0.34
MAPT P10636 2/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
KDM4E B2RXH2 1/20 0.33
POLB P06746 1/20 0.33
PKM P14618 1/20 0.33
RECQL P46063 1/20 0.33
SENP1 Q9P0U3 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3945392 0.82 KDM4E (0.34) BCL2MCL1BADGAAMAPT
SCHEMBL4042523 0.81 KDM4E (0.49) BCL2MCL1BADGAAPTGS1
Hydrochloric Acid SCHEMBL3594989 0.81 KDM4E (0.33) BCL2MCL1BADMAPTMEN1
SCHEMBL27616643 0.78 MAPT (0.40) GAAPTGS2MAPTMEN1KMT2A
SCHEMBL3596105 0.78 LMNA (0.36) BCL2MCL1BADGAACSNK2A2
SCHEMBL12852133 0.77 BCL2 (0.47) BCL2MCL1BADGAACSNK2A2
SCHEMBL2911832 0.73 LMNA (0.42) GAAMAPTMEN1KMT2AKDM4E
SCHEMBL2789306 0.73 HSP90AA1 (0.32) GAAMAPTKMT2ATNKSPARP1
SCHEMBL3603534 0.72 MAOB (0.38) BCL2MCL1BADGAAMAPT
SCHEMBL4035850 0.72 MAPT (0.38) BCL2MCL1BADMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1323716-B1 PROMOTERS FOR THE PROLIFERATION AND DIFFERENTIATION OF STEM CELLS AND/OR NEURON PRECURSOR CELLS TAKEDA PHARMACEUTICAL (JP) 2009-01-14 EP disclosed
US-20090012081-A1 Agents for promoting the proliferation or differentiation of stem cells or neural progenitor cells TAKEDA PHARMACEUTICAL COMPANY LTD. (JP) 2009-01-08 US disclosed
US-7008950-B1 Benzofurans as suppressors of neurodegeneration TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2006-03-07 US disclosed
US-20040034049-A1 Promoters for the proliferation and differentiation of stem cells and/or neuron precursor cells TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-02-19 US disclosed
EP-1323716-A1 PROMOTERS FOR THE PROLIFERATION AND DIFFERENTIATION OF STEM CELLS AND/OR NEURON PRECURSOR CELLS Takeda Chemical Industries, Ltd. (JP) 2003-07-02 EP disclosed
EP-0988289-A2 HETEROCYCLIC COMPOUNDS, THEIR PRODUCTION AND USE Takeda Pharmaceutical Company Limited (JP) 2000-03-29 EP disclosed
WO-1998055454-A2 BENZOFURANS AND BENZOTHOPHENES AS SUPPRESSORS OF NEURODEGENERATION TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1998-12-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090012081-A1 Agents for promoting the proliferation or differentiation of stem cells or neural progenitor cells NES, MKI67, CCNO BCL2 104/4885MCL1 36/4885BAD 319/4885
US-20040034049-A1 Promoters for the proliferation and differentiation of stem cells and/or neuron precursor cells NES, HAT1, PROX1 BCL2 306/4885MCL1 147/4885BAD 985/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.